Creative Biolabs Opens Applications for the 2024 Scholarship Program

May 09 16:57 2024
Creative Biolabs, a leading CRO, is proud to announce the opening of applications for its 2024 scholarship program. The initiative aims to provide financial assistance to students within the biotechnology industry, supporting their academic pursuits and research endeavors.

New York, USA – May 9, 2024 – The Creative Biolabs Scholarship Program reflects the company’s commitment to nurturing the next generation of biotech talent. As a renowned provider of biopharmaceutical development solutions, Creative Biolabs recognizes the importance of investing in the education and advancement of young scientists and researchers.

“We are excited to launch our 2024 scholarship program, which underscores our dedication to fostering innovation and excellence in the field of biotechnology,” according to a scientist at Creative Biolabs. “Through this initiative, we aim to empower students to pursue their academic and professional aspirations, ultimately contributing to the advancement of the biotech industry.”

The scholarship program opens to undergraduate, graduate, and doctoral students pursuing studies in science-related fields, with a focus on areas such as immunology, biochemistry, and molecular biology, which play a crucial role in the development of novel biopharmaceuticals and are key areas of focus for Creative Biolabs. Applicants will be evaluated based on academic merit, research achievements, leadership potential, and a personal statement outlining their career goals and aspirations in biotechnology.

“In addition to financial support, the recipients have the chance to learn more about the exclusive resources and networking opportunities within the biotech community. This includes access to Creative Biolabs’ cutting-edge technologies and platforms, such as high-throughput hybridoma generation, B cell sorting, and de novo antibody sequencing.” The scientist elaborated.

High-Throughput Hybridoma Generation

One of the key technologies offered by Creative Biolabs is the powerful Hyperdoma™, by far the most comprehensive and advanced hybridoma generation and screening platform, incorporating high-throughput screening systems like ClonePix 2, FMAT, and Celigo Image Cytometer. It fully takes advantage of the hybridoma machinery to sift out the best antibodies for any research goal, and meanwhile, its electrofusion and advanced screening approaches generate an expanded positive clone pool to largely maximize the possibility of producing the most viable clone, essential for the production of monoclonal antibodies. Utilizing this technology, researchers can significantly accelerate the process of antibody development and maximize their research efficiency.

De Novo Antibody Sequencing

Another important solution is de novo antibody sequencing, which achieves 100% accuracy in interpreting antibody sequences and covers V, J, and C gene segments, the CDR3 region, fluorochrome mAbs, non-standard antibodies, and isobaric amino acids.

“Our scholarship recipients will have the opportunity to engage with industry-leading experts and learn more about state-of-the-art technologies like those above to further their research endeavors,” said the scientist. “We believe that by investing in the education and development of talented students, we can drive innovation and advance the frontiers of biotechnology.”

Interested students can find more information and apply for the scholarship program at


Creative Biolabs, specializing in biopharmaceutical development, offers a range of antibody discovery services. With a focus on nurturing talent, Creative Biolabs annually provides scholarships to biotech students, reflecting its dedication to education and innovation.


Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States